SCHEMBL5813730

SCHEMBL5813730

COc1ccc(-c2nc(C3(O)CCN(C(=O)OC(C)(C)C)CC3)sc2-c2ccnc(NC3CCCC3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
DYRK1A Q13627 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
DYRK2 Q92630 2/20 0.40
HTT P42858 2/20 0.39
SYK P43405 3/20 0.39
ALOX5 P09917 1/20 0.39
CDK1 P06493 1/20 0.38
CDK4 P11802 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNA2 P20248 1/20 0.38
CCND1 P24385 1/20 0.38
CDK2 P24941 1/20 0.38
CCND3 P30281 1/20 0.38
CDK7 P50613 1/20 0.38
CCNH P51946 1/20 0.38
CDK6 Q00534 1/20 0.38
MMP1 P03956 3/20 0.38
MMP3 P08254 3/20 0.38
MMP7 P09237 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819436 0.99 ALDH1A1 (0.43) ALDH1A1DYRK1AGPR119DYRK2HTT
SCHEMBL5814237 0.97 ALDH1A1 (0.45) ALDH1A1DYRK1AGPR119DYRK2HTT
SCHEMBL5813784 0.92 DYRK2 (0.43) DYRK2SYKALOX5CDK1CDK4
SCHEMBL5818721 0.91 DYRK2 (0.43) DYRK2SYKALOX5CDK1CDK4
SCHEMBL5817914 0.89 PRKD3 (0.44) DYRK2SYKCDK2
SCHEMBL5819839 0.87 MAPK14 (0.42) GPR119DYRK2SYKCDK1CDK4
SCHEMBL5819371 0.87 IKBKB (0.43) ALDH1A1CDK1CDK4CCNB1CCNA2
SCHEMBL5819074 0.87 ALDH1A1 (0.47) ALDH1A1DYRK1AGPR119DYRK2HTT
SCHEMBL5818643 0.86 MAPK14 (0.41) GPR119DYRK2SYKCDK1CDK4
SCHEMBL5819127 0.86 BRAF (0.44) DYRK2SYKCDK1CDK4CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed